Surgery News and Research

RSS

RPCs transplant appears to improve kidney structure and function in rat models

Transplanting autologous renal progenitor cells, into rat models with kidney damage from pyelonephritis - a type of urinary infection that has reached the kidney - has been found to improve kidney structure and function.

14 Feb 2011

State Roundup: Calif. adult day care; S.C.'s budget cuts; Minn. 'boomer bust'

As Gov. Jerry Brown has proposed slashing government aid for poor people, he argues that California still provides more generous benefits than many other states. … State-by-state comparisons are complicated. ... While California pays health costs for a larger share of its population, it spends less per person. It reimburses health care providers less and covers a younger, healthier group of people (Yamamura, 2/14).

14 Feb 2011

bioMD makes offer for Allied Medical

bioMD Limited (ASX: BOD), a company with assets in regenerative tissue engineering technologies today announced that it has made an offer to buy all of the shares in Allied Medical Limited (Allied), a public unlisted company that specialises in the sales, distribution and commercialisation of medical technologies.

14 Feb 2011

Kyocera and JMM open new Orthopedic Design Center in the U.S.

Kyocera Industrial Ceramics Corp., Orthopedic Division, today unveiled its new Orthopedic Design Center in Somerset, N.J., formed in collaboration with Japan Medical Materials Corporation (JMM) - a Kyocera Group company.

14 Feb 2011

Sequencing of whole prostate cancer genomes - an historic development

Today's announcement regarding the sequencing of whole prostate cancer genomes is an historic development in the fight against prostate cancer. The ability to sequence whole genomes will spare some patients from unnecessary treatments and side effects while eliminating an estimated $1.5 billion that is spent each year on overtreatment. The complete research findings will be published in the February 10 issue of Nature.

14 Feb 2011

JDR releases research report on Osteonecrosis of the jaw

Osteonecrosis of the jaw is a debilitating bone condition that affects the jaws and occurs as a result of reduced local blood supply to the bone. The literature in this area has been severely limited since most investigations cannot evaluate sufficient numbers of afflicted individuals to accurately determine the incidence of the disease and associated risk factors.

14 Feb 2011

Two Uofl professors provide reference works in oncology field

Two University of Louisville School of Medicine professors recently authored reference works in the field of oncology, one focusing on the use of radiation treatment for childhood cancers and the other on hepatocellular carcinoma, or liver cancer.

14 Feb 2011

New clinical trial to test surgery specifically for Type 2 diabetes

A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, as well or even better than the best medical treatment available today. This is the first study of its kind open to patients who are overweight or mildly obese.

14 Feb 2011

JTH publishes positive TB-402 Phase II trial results for VTE treatment after orthopaedic surgery

ThromboGenics NV and co-development partner BioInvent International announce today that the positive TB-402 Phase II trial results, evaluating the product's efficacy and safety for the prevention of venous thromboembolism afterorthopaedic surgery, have been published in the Journal of Thrombosis and Haemostasis.

14 Feb 2011

Silent strokes can cause long-term cognitive, learning deficits in children with sickle cell disease

Silent strokes, which have no immediate symptoms but could cause long-term cognitive and learning deficits, occur in a significant number of severely anemic children, especially those with sickle cell disease, according to research presented at the American Stroke Association's International Stroke Conference 2011.

13 Feb 2011

Genetic map for prostate cancer

Researchers have managed to uncover the whole genetic sequence in prostate cancer. This complete map, hope researchers, will eventually lead to the development of more targeted drugs and a better understanding of which prostate cancers are likely to spread, one of the biggest challenges for physicians and patients.

13 Feb 2011

Genes for prostate cancer mapped for the first time

A genetic blue print that uncovers many of the mutations and genetic damage that drives prostate cancer and could lead to new treatments and better diagnosis has been found. This would mean earlier detection and new breeds of drugs to reverse the damage. Also each patient could have his own “cancer chart” made so that his treatment is personalized. The study, conducted by researchers from the Broad Institute, Dana-Farber Cancer Institute and Weill Cornell Medical College, appears in the Feb. 10 issue of Nature.

13 Feb 2011

Surgical procedure to repair spina bifida while still in the uterus may help the baby walk after birth

More than two thousand physicians, some of the top obstetric/gynecologists in the world who specialize in maternal-fetal medicine, especially high risk pregnancies, gathered today for their annual meeting in San Francisco to begin four days of intensive research presentations. Presentations each year at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, represent major findings in reducing high-risk pregnancies and complications.

11 Feb 2011

FDA grants Stryker 510(k) clearance for MDM X3 Mobile Bearing Hip System

Stryker Corporation's Orthopaedics Division today announced U.S. Food and Drug Administration 510(k) clearance for its MDM X3 Modular Dual Mobility Mobile Bearing Hip System. MDM X3 is an addition to the company's portfolio of next-generation technologies designed to minimize the risks traditionally associated with hip replacement surgery and address a broader patient population, including both primary and revision total hip arthroplasty candidates.

From Stryker 11 Feb 2011

Genetic testing for inherited blood-clotting abnormalities not routinely recommended for VTE patients

Genetic testing for inherited blood-clotting abnormalities is not routinely recommended for patients with venous thromboembolism (VTE) of unknown cause, according to a new expert panel statement in a recent issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics (ACMG).

11 Feb 2011

Cancer cells 'addicted' to self-preservation process

A team of investigators at The Cancer Institute of New Jersey (CINJ); Rutgers, The State University of New Jersey; and Princeton University, have determined that cancer cells are "addicted" to a self-preservation process known as autophagy. They also showed that the inhibition of that process could prove to be a valuable treatment approach for aggressive cancers. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

11 Feb 2011

AAOS appreciates FDA's communication on metal-on-metal hip components in total hip arthroplasty

The U.S. Food and Drug Administration (FDA) today posted a public health communication about metal-on-metal hip components used in total hip arthroplasty (THA). The American Academy of Orthopaedic Surgeons (AAOS) appreciates this thorough and well-considered look at the concerns surrounding the use of these implants.

11 Feb 2011

New trial tests surgery for Type 2 diabetes

11 Feb 2011

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Medical researchers from The University of Texas Health Science Center at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStem-, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke.

11 Feb 2011

Seven-year study demonstrates clear benefits of fetal surgery to treat spina bifida in babies

Results of a landmark, seven-year National Institutes of Health-funded trial, Management of Myelomeningocele Study (MOMS), demonstrate clear benefit for babies who undergo fetal surgery to treat spina bifida, the most common birth defect in the central nervous system.

11 Feb 2011

Surgery News and Research

RPCs transplant appears to improve kidney structure and function in rat models

State Roundup: Calif. adult day care; S.C.'s budget cuts; Minn. 'boomer bust'

bioMD makes offer for Allied Medical

Kyocera and JMM open new Orthopedic Design Center in the U.S.

Sequencing of whole prostate cancer genomes - an historic development

JDR releases research report on Osteonecrosis of the jaw

Two Uofl professors provide reference works in oncology field

New clinical trial to test surgery specifically for Type 2 diabetes

JTH publishes positive TB-402 Phase II trial results for VTE treatment after orthopaedic surgery

Silent strokes can cause long-term cognitive, learning deficits in children with sickle cell disease

Genetic map for prostate cancer

Genes for prostate cancer mapped for the first time

Surgical procedure to repair spina bifida while still in the uterus may help the baby walk after birth

FDA grants Stryker 510(k) clearance for MDM X3 Mobile Bearing Hip System

Genetic testing for inherited blood-clotting abnormalities not routinely recommended for VTE patients

Cancer cells 'addicted' to self-preservation process

AAOS appreciates FDA's communication on metal-on-metal hip components in total hip arthroplasty

New trial tests surgery for Type 2 diabetes

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Seven-year study demonstrates clear benefits of fetal surgery to treat spina bifida in babies

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News